Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPOG.L Regulatory News (POG)

  • There is currently no data for POG

Director/PDMR Shareholding

18 Mar 2015 12:23

RNS Number : 7879H
Petropavlovsk PLC
18 March 2015
 

 

THIS ANNOUNCEMENT IS NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE RUSSIAN FEDERATION, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT WOULD BE UNLAWFUL TO DO SO. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE ANNOUNCEMENT. THIS ANNOUNCEMENT IS NOT AN OFFER OF SECURITIES FOR SALE IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE RUSSIAN FEDERATION, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT WOULD BE UNLAWFUL TO SO OFFER.

 

THIS ANNOUNCEMENT IS AN ADVERTISEMENT AND NOT A PROSPECTUS AND INVESTORS SHOULD NOT SUBSCRIBE FOR OR PURCHASE ANY SECURITIES REFERRED TO IN THIS ANNOUNCEMENT EXCEPT ON THE BASIS OF THE INFORMATION CONTAINED IN THE PROSPECTUS PUBLISHED IN CONNECTION WITH THE RIGHTS ISSUE AND NOT IN RELIANCE ON ANY INFORMATION IN THIS ANNOUNCEMENT. COPIES OF THAT PROSPECTUS ARE AVAILABLE FREE OF CHARGE TO ELIGIBLE PERSONS FROM THE COMPANY'S REGISTERED OFFICE. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN ADVERTISEMENT OF ANY

SECURITIES IN THE RUSSIAN FEDERATION.

 

 

18 March 2015

Petropavlovsk PLC

 

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility ("PDMR") or Connected Persons

 

Petropavlovsk PLC (the "Company" and, together with its subsidiaries, the "Group") announces that the following directors and/or their connected persons have notified the Company that they have taken up, to the extent set out below, their entitlement to acquire New Ordinary Shares under the Rights Issue approved by Shareholders on 26 February 2015. Under the Rights Issue, Qualifying Shareholders had the right to acquire 157 New Ordinary Shares for every 10 Existing Ordinary Shares held at the close of business on 24 February 2015 at a price of 5p per Ordinary Share.

 

In each case the issue date of New Ordinary Shares subscribed pursuant to the Rights Issue was 16 March 2015 and the subscription price was 5p per share.

 

The Company has also today been notified of the interests summarised in Note (1) below, which were allotted on 18 March 2015.

 

Director

Number of shares subscribed pursuant to the Rights Issue

Number of shares subscribed pursuant to the Underwriting / Founders' Arrangements

Holding following this announcement

% of total current voting rights2

Mr Peter Hambro and Associates1

13,676,462

131,830,466

152,280,861

4.645%

Dr Pavel Maslovskiy and Associates1

76,208,154

131,830,466

215,553,105

6.575%

Mr Martin Smith

292,491

0

311,121

0.009%

Mr Andrey Maruta

11,789

0

33,925

0.001%

Dr Alya Samokhvalova

292,491

0

311,121

0.009%

Mr Dmitry Chekashkin

4,742,475

0

4,761,104

0.145%

Dr Graham Birch

247,746

0

263,526

0.008%

Sir Malcolm Field

831,001

0

883,931

0.027%

Dr David Humphreys

30,049

0

31,963

0.001%

Sir Roderic Lyne

26,831

0

28,540

0.001%

Mr Charles McVeigh III

7,850

0

8,350

0.000%

 

Notes:

 

(1) Under the Founders Arrangements described in the Prospectus, Vailaski Holdings Limited will be subscribing for 395,491,398 New Ordinary Shares pursuant to the underwriting arrangements. Each of Mr Hambro and Dr Maslovskiy will have call and voting rights and will be subject to put rights in respect of one third of these Shares. These additional New Ordinary Shares are all being issued at 5p per share.

 

(2) The percentage of voting rights is determined using 3,278,187,139 voting rights as at 18 March 2015.

 

This announcement is made in accordance with DTR 3.1.4R and relates to transactions notified to the Company in accordance with DTR 3.1.2R.

 

In addition the Company has been advised by the Employee Benefit Trust that it sold 18,852,116 nil-paid rights in order to subscribe for 226,225 new Ordinary Shares. The Employee Benefit Trust has an interest in 1,441,406 ordinary shares representing 0.044% of the enlarged voting rights.

 

Capitalised terms not otherwise defined in this announcement have the meanings given to them in Part 14 of the combined prospectus and circular dated 2 February 2015 issued by the Company (the "Prospectus").

 

Enquiries

 

Petropavlovsk PLC

Alya Samokhvalova, Group Head of External Communications,

11 Grosvenor Place, London, SW1X 7HH

T: +44 (0) 20 7201 8900 | E: as@petropavlovsk.net

 

Bank of America Merrill Lynch

Corporate Broker

Simon Davy, Managing Director,

2 King Edward Street, London, EC1A 1HQ

T: +44 (0) 20 7995 3759 | E: simon.davy@baml.com

 

Maitland

Media Contact

Neil Bennett, Chief Executive Officer

Orion House, 5 Upper St Martin's Lane, London WC2H 9EA

T: +44 (0) 20 7379 5151 | E: Petropavlovsk-Maitland@Maitland.co.uk

 

This announcement is for information purposes only and does not constitute an invitation or offer to buy, sell,

issue, underwrite, acquire or subscribe for, or the solicitation of an offer to buy, sell, issue, acquire or subscribe for any Nil Paid Rights, Fully Paid Rights and New Ordinary Shares (the "Securities"), nor shall there be any sale of any Securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. Any failure to comply with these restrictions may constitute a violation of the securities laws of such

jurisdictions.

 

In particular, this announcement does not constitute or form part of any offer to buy, sell, issue, acquire, exchange, transfer or subscribe for, or the solicitation of an offer to buy, sell, issue, acquire, exchange, transfer or subscribe for, any Securities in Australia, Canada, Japan, the Russian Federation (or to the benefit of a Russian person or any person in the Russian Federation or any other person, except as may be

permitted by Russian law), the Republic of South Africa or any other jurisdiction into which such offer or solicitation would be unlawful. No public offering of any Securities referred to herein is being made in Australia, Canada, Japan, the Russian Federation, the Republic of South Africa or any other jurisdiction where such a public offering would be unlawful.

 

This announcement is not an offer of any Securities for sale in the United States. The Securities referred to above have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "US Securities Act") or under any securities laws of any state or other jurisdiction of the United States and may not be offered or sold in the United States except pursuant to an applicable exemption from or in a transaction not subject to the registration requirements of the United States in the US Securities Act and the rules and regulations thereunder. There has not been and will not be a public offer of the Securities in the

United States.

 

Acquiring investments to which this announcement relates may expose an investor to a significant risk of losing all of the amount invested. Persons considering making such investments should consult an authorised person specialising in advising on such investments.

 

The distribution of this announcement in certain jurisdictions may be restricted by law. No action has been taken that would permit an offering of any Securities or possession or distribution of this announcement or any other offering or publicity material relating to such Securities in any jurisdiction where action for that purpose is required. Persons into whose possession this announcement comes are required to inform themselves about, and to observe, such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

The content of any websites referred to in this announcement does not form part of this announcement.

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSFEFEAFISEED
Date   Source Headline
18th Jul 20224:38 pmRNSAppointment of Administrators
14th Jul 20222:53 pmRNSUpdate on Application to Appoint Administrators
12th Jul 20227:42 amRNSNotice of Application for an Administration Order
12th Jul 20227:30 amRNSSuspension - Petropavlovsk Plc
11th Jul 202210:11 amRNSUpdate on Convertible Bonds
4th Jul 202210:49 amRNSHolding(s) in Company
1st Jul 20224:09 pmRNSResignation of Auditor
27th Jun 20224:30 pmRNSMoscow Exchange Listing Level Re-classification
7th Jun 202212:34 pmRNSChange of Accounting Reference Date & Corp. Update
23rd May 20224:40 pmRNSSecond Price Monitoring Extn
23rd May 20224:35 pmRNSPrice Monitoring Extension
20th May 20224:41 pmRNSSecond Price Monitoring Extn
20th May 20224:36 pmRNSPrice Monitoring Extension
18th May 20224:41 pmRNSSecond Price Monitoring Extn
18th May 20224:36 pmRNSPrice Monitoring Extension
17th May 20224:40 pmRNSSecond Price Monitoring Extn
17th May 20224:35 pmRNSPrice Monitoring Extension
16th May 202211:47 amRNSUpdate on Gazprombank Debt
13th May 20224:40 pmRNSSecond Price Monitoring Extn
13th May 20224:35 pmRNSPrice Monitoring Extension
12th May 20228:45 amRNSUpdate on Debt and Gold Sales
29th Apr 202211:08 amRNSUpdate on Guaranteed Notes and Convertible Bonds
27th Apr 20224:41 pmRNSSecond Price Monitoring Extn
27th Apr 20224:36 pmRNSPrice Monitoring Extension
25th Apr 20224:35 pmRNSPrice Monitoring Extension
22nd Apr 20224:40 pmRNSSecond Price Monitoring Extn
22nd Apr 20224:35 pmRNSPrice Monitoring Extension
22nd Apr 20227:00 amRNSQ1 2022 Production and Sales Report
20th Apr 20224:41 pmRNSSecond Price Monitoring Extn
20th Apr 20224:35 pmRNSPrice Monitoring Extension
20th Apr 20227:00 amRNSUpdate Regarding Gazprombank
19th Apr 20224:41 pmRNSSecond Price Monitoring Extn
19th Apr 20224:36 pmRNSPrice Monitoring Extension
14th Apr 20224:41 pmRNSSecond Price Monitoring Extn
14th Apr 20224:35 pmRNSPrice Monitoring Extension
14th Apr 20227:00 amRNSUpdate Regarding Gazprombank and Corporate Options
12th Apr 20224:40 pmRNSSecond Price Monitoring Extn
12th Apr 20224:35 pmRNSPrice Monitoring Extension
11th Apr 20227:00 amRNSBoard Update
8th Apr 20224:41 pmRNSSecond Price Monitoring Extn
8th Apr 20224:36 pmRNSPrice Monitoring Extension
7th Apr 202212:44 pmRNSHolding(s) in Company
6th Apr 202210:47 amRNSHolding(s) in Company Replacement
5th Apr 20226:20 pmRNSHolding(s) in Company
4th Apr 20224:40 pmRNSSecond Price Monitoring Extn
4th Apr 20224:36 pmRNSPrice Monitoring Extension
4th Apr 20223:52 pmRNSBoard Update
1st Apr 20227:00 amRNSNotice of Change to Director Details
30th Mar 20224:40 pmRNSSecond Price Monitoring Extn
30th Mar 20224:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.